Experimental Gene Therapy Successful In Certain Lymphomas And Leukemia
Study results of CD19-directed chimeric antigen receptor (CAR) therapy
using the Sleeping Beauty non-viral transduction system to modify T
cells has demonstrated further promise in patients with advanced
hematologic malignancies.
Source: M. D. Anderson Cancer Center - News Releases - Category: Cancer & Oncology Source Type: news
More News: Cancer | Cancer & Oncology | Gene Therapy | Genetics | Hematology | Leukemia | Lymphoma | Study